Status:
COMPLETED
Dosing Iodinated Contrast Media According to Lean vs. Total Body Weight
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Contrast Media Dosing
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the effect of dosing iodinated contrast media according to a patient's total body weight vs. lean body weight. Participants will be randomized into 2 groups ba...
Eligibility Criteria
Inclusion
- outpatients only
- patients scanned on modern Siemens scanners at our institution
Exclusion
- self-reported history of chronic kidney, heart or liver disease
- allergy to iodinated contrast
- acute illness
- outside maximum threshold limit for weight-based contrast dosing
- pregnancy
- image degradation
Key Trial Info
Start Date :
February 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 9 2018
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT03415997
Start Date
February 21 2018
End Date
November 9 2018
Last Update
January 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 2Y9